 |
|
|
| |
Utilization of Emtricitabine/Tenofovir Disoproxil Fumarate (FTC/TDF) for HIV Pre-Exposure Prophylaxis (PrEP) in the United States by Age, Gender and Race/Ethnicity (2014 - 2017)
|
| |
| |
Reported by Jules Levin
10th IAS Conference on HIV Science (IAS 2019), 21-24 July 2019, Mexico City, Mexico
C Nguyen, T Hawkins, J Anderson, S Bush, T Dinh, S McCallister, R Mera
Gilead Sciences, Inc., Foster City, CA, USA
|
| |
|
|
|
|
|
